Hope Biosciences Research Foundation

This study provided an experimental stem cell treatment to one child with a rare form of congenital muscular dystrophy caused by a LMNA gene mutation. The child received 14 intravenous infusions of their own banked stem cells. The goal was to see if the treatment is safe and can …

This study aimed to test whether infusions of donated stem cells could safely improve symptoms in children with juvenile idiopathic arthritis. It was designed for 66 participants aged 2 to 17 with either oligoarticular or polyarticular forms of the disease. However, the trial was…

This study tests whether stem cells taken from a person's own belly fat and given through an IV can help people with relapsing-remitting multiple sclerosis. Ten adults who previously received a placebo in an earlier trial will get multiple infusions of these cells. The main goal …

This study gave eight infusions of the patient's own stem cells to one person with cerebral palsy who had no other options. The goal was to improve his quality of life. The treatment is not a cure, and the patient may need ongoing care.

This study tests a stem cell therapy for people with long-term spinal cord injuries. It uses the patient's own fat cells to try to repair nerve damage and restore feeling or movement. The treatment is given to individual patients under special FDA permission, and aims to improve …

This expanded access program tested the safety of multiple intravenous infusions of a patient's own stem cells (HB-adMSCs) for treating Parkinson's disease. It involved 10 patients aged 76 to 95 who did not qualify for other studies. Each patient received 200 million stem cells o…

This study tested a stem cell treatment for one person with ALS, a progressive nerve disease. The treatment used the patient's own fat-derived stem cells to try to control the disease. The study is no longer available for new participants.

This study provides an experimental stem cell treatment (HB-adMSCs) to one 83-year-old man with Primary Lateral Sclerosis, a rare nerve disease that causes muscle weakness. The goal is to see if the treatment is safe and can slow the disease. The patient had already banked his ow…

This study provides expanded access to HB-adMSCs (stem cells) for adults with systemic lupus erythematosus (SLE). Participants must have their own stem cells banked at Hope Biosciences. The goal is to evaluate safety and effectiveness in controlling the disease.

This expanded access program offers an experimental stem cell treatment to up to 11 people with Parkinson's disease who were not chosen for the main study. The treatment uses the patient's own fat-derived stem cells given through an IV. The goal is to see if it is safe and can he…

This study tests the safety and early effects of using a patient's own stored stem cells to treat chronic inflammatory demyelinating polyneuropathy (CIDP), a rare nerve disorder. Only one patient who has banked their stem cells at the sponsor's facility can join. The treatment in…

This study provides an 84-year-old man who had a severe ischemic stroke with access to an experimental treatment using his own stem cells (HB-adMSCs). The goal is to see if the treatment is safe and may help control the damage from the stroke. The patient received the cells after…

This study gave a 58-year-old man with POEMS syndrome eight infusions of his own stem cells over 28 weeks to help relieve nerve pain and weakness. The treatment was only available to him because he had already stored his stem cells. The study is no longer enrolling patients.

This study gave multiple infusions of a type of stem cell (HB-adMSCs) to one person with long-term muscle or joint pain. The goal was to see if it could safely reduce pain and improve quality of life. The study lasted about 32 weeks and included several visits for infusions and c…

This study tested a stem cell treatment in one person with long-term knee pain from osteoarthritis who had no other options left. The patient received stem cells from their own fat, given through a vein and directly into both knees. The goal was to see if it is safe and if it can…

This study gave adults aged 18-65 with Post-COVID-19 Syndrome (long COVID) access to an experimental stem cell treatment called HB-adMSCs, added to their usual care. The goal was to see if it could safely ease lingering symptoms like fatigue or brain fog. The study is no longer a…